Chinese english Germany Japanese Korea

HQ-415

HQ-415 Struktur
430462-93-4
CAS-Nr.
430462-93-4
Englisch Name:
HQ-415
Synonyma:
HQ-415;CS-2051;HQ 415,HQ415;7-[(3-ethoxy-4-methoxyphenyl)-[(4-methylpyridin-2-yl)amino]methyl]quinolin-8-ol;8-Quinolinol, 7-[(3-ethoxy-4-methoxyphenyl)[(4-methyl-2-pyridinyl)amino]methyl]-
CBNumber:
CB13041410
Summenformel:
C25H25N3O3
Molgewicht:
415.48
MOL-Datei:
430462-93-4.mol
Request For Quotation

HQ-415 Eigenschaften

Siedepunkt:
614.9±55.0 °C(Predicted)
Dichte
1.246±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO : 5.6 mg/mL (13.48 mM)
pka
4.13±0.50(Predicted)

Sicherheit

HQ-415 Chemische Eigenschaften,Einsatz,Produktion Methoden

HQ-415 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

HQ-415 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 21)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Career Henan Chemica Co 		+86-0371-86658258 15093356674;
 laboratory@coreychem.com China 30255 58
Haoyuan Chemexpress Co., Ltd. 021-58950125
info@chemexpress.com China 7553 61
MedChemexpress LLC 021-58955995
sales@medchemexpress.cn United States 4863 58
Musechem +1-800-259-7612
info@musechem.com United States 4662 60
Shenzhen Regent Biochemical Technology Co., Ltd. 0755-0755-85201366 18938635012
 sales@regentsciences.com China 9293 58
DC Chemicals 021-58447131 13564518121
 sales@dcchemicals.com China 9414 58
Cckinase, Inc. +1 (732)236-3202
sales@cckinase.com United States 2738 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
 sales@chemegen.com China 11289 58
Absin Bioscience Inc. 021-38015121 15000105423
 chenjw@absin.cn China 24734 58
  • HQ-415
  • 7-[(3-ethoxy-4-methoxyphenyl)-[(4-methylpyridin-2-yl)amino]methyl]quinolin-8-ol
  • CS-2051
  • 8-Quinolinol, 7-[(3-ethoxy-4-methoxyphenyl)[(4-methyl-2-pyridinyl)amino]methyl]-
  • HQ 415,HQ415
  • 430462-93-4
Copyright 2019 © ChemicalBook. All rights reserved